Effect of a Cepham Supplement on Hot Flashes and Menopausal Symptoms in Postmenopausal Women

ConditionD008593
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age40-60
SponsorJacksonville University

About this trial

The goal of this clinical trial is to learn if a daily nutritional supplement can reduce hot flashes and other menopausal symptoms in postmenopausal women.

The main questions this study aims to answer are:

Does the supplement reduce the number and severity of daily hot flashes?

Does it improve other common menopausal symptoms?

Researchers will compare the supplement to a placebo (a look-alike capsule with no active ingredients) to see if it helps manage symptoms during menopause.

Participants will:

Take either the supplement or a placebo daily for 30 days

Track their hot flashes each day using a short online survey

Complete a symptom questionnaire at the beginning and end of the study

This study is for women ages 40-60 who have been postmenopausal for at least one year and currently experience bothersome hot flashes.

Eligibility criteria

Qualifiers

Adult women aged 40-60 years.

Menopause Rating Scale score: (a) GE 14 and (b) score of 3 or 4 (severe to very severe) for hot flashes (Blumel et al., 2018).

Disqualifiers

Current use of hormone therapy or other medications known to affect hot flashes.

Significant comorbidities that may interfere with study participation.

Trial design

Treatments tested in this trial

  • Shatavari Root Extract, oral capsule

Treatment groups

44 Participants
are divided into 2 treatment groups

Sponsors and collaborators